Amadori S et al.
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.
Blood 2005;106:27-34.
Ascioglu S et al.
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
Clin Infect Dis 2002;34:7-14.
ASCO.
2006 Update of the ASCO Recommendations for Antiemetics in Oncology: Guideline Summary.
J Oncol Pract 2006;2:193-195.
Baden LR
Prophylactic Antimicrobial Agents and the Importance of Fitness.
N Engl J Med 2005;353:1052-1054.
Baer MR et al.
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia.
Blood 1996;87:1484-1494.
Benoit DD et al.
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.
Intensive Care Med 2006;32:93-99.
Benson K et al.
The Platelet-Refractory Bone Marrow Transplant Patient: Prophylaxis and Treatment of Bleeding.
Sem Oncol 1993;20(Suppl6):102-109.
Bohme A et al.
Treatment of fungal infections in hematology and oncology - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Ann Hematol 2003;82(Suppl2):133-140.
Bosly A et al.
Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.
Cancer 2003;98:1048-1054.
Bucaneve G et al.
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
N Engl J Med 2005;353:977-987.
Cometta A et al.
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
Clin Infect Dis 2003;37:382-389.
Cornely OA et al.
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
N Engl J Med 2007;356:348-359.
Cullen M et al.
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
N Engl J Med 2005;353:988-998.
Darmon M et al.
Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy.
Crit Care Med 2005;33:2488-2493.
DGHO (Deutsche Gesellschaft für Hämatologie und Onkologie).
Empfehlungen zur Thrombozytentransfusion 2006.
http://www.dgho.de/_cmsdata/_file/file_173.pdf, 18.2.2008
Freifeld AG et al.
Antibacterial Prophylaxis in Patients with Cancer and Neutropenia.
N Engl J Med 2006;354:90-94.
Freifeld AG et al.
Prevention and Treatment of Cancer-Related Infections. NCCN 2008.
www.nccn.org/professionals/physician_gls/PDF/infections.pdf, 18.2.2008.
Gafter-Gvili A et al.
Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.
J Antimicrob Chemother 2007;59:5-22.
Garcia-Carbonero R, Paz-Ares L.
Antibiotics and growth factors in the management of fever and neutropenia in cancer patients.
Curr Opin Hematol 2002;9:215-221.
Godwin JE et al.
A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).
Blood 1998;91:3607-3615.
Hillyer CD et al.
Bacterial Contamination of Blood Components: Risks, Strategies, and Regulation.
ASH, Education Program Book 2003;575-589.
www.asheducationbook.org, 18.2.2008.
Itoh M et al.
Effects of the rational use of corticosteroids eye drops for the prevention of ocular toxicity in high-dose cytosine arabinoside therapy.
Yakugaku Zasshi 1999;119:229-235.
Jaksic B et al.
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Clin Infect Dis 2006;42:597-607.
Kawano-Yamamoto C et al.
Leuprorelin acetate for female patients with newly diagnosed acute leukemia receiving chemotherapy.
Int J Hematol 2007;86:199-201.
Kompetenznetz "Akute und chronische Leukämien".
Supportive Therapie.
www.kompetenznetz-leukaemie.de, 18.2.2008.
Kris MG et al.
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
J Clin Oncol 2006;24:2932-2947.
Lass JH et al.
Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine.
Am J Ophthalmol 1982;94:617-621.
Lazarus HM et al.
Comparison of the prophylactic effects of 2-deoxycytidine and prednisolone for high-dose intravenous cytarabine-induced keratitis.
Am J Ophthalmol 1987;104:476-480.
Lhomme C et al.
Prevention of menstruation with leuprorelin (GnRH agonist) in women undergoing myelosuppressive chemotherapy or radiochemotherapy for hematological malignancies: a pilot study.
Leuk Lymphoma 2001;42:1033-1041.
Link H, Buchheidt D, Maschmeyer G.
Infektionen bei Neutropenie - Empfehlungen für die Praxis.
DGHO 2006. www.dgho-infektionen.de, 18.2.2008.
Link H et al.
Antimicrobial therapy of unexplained fever in neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG - German Cancer Society).
Ann Hematol 2003;82(Suppl2):105-117.
Lowenberg B et al.
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.
N Engl J Med 2003;349:743-752.
Matteucci P et al.
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Haematologica 2006;91:255-257.
Meirow D et al.
Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
Cancer 2006;107:1634-1641.
Pappas PG et al.
Guidelines for treatment of candidiasis.
Clin Infect Dis 2004;38:161-189.
Paul M et al.
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Cochrane Database Syst Rev 2003;CD003038.
Rex JH et al.
Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Clin Infect Dis 2000;30:662-678.
Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Aufgestellt gemäß Transfusionsgesetz von der Bundesärztekammer im Einvernehmen mit dem Paul-Ehrlich-Institut.
Gesamtnovelle 2005 mit Änderungen und Ergänzungen 2007.
Deutscher Ärzte-Verlag, Köln.
Roila F, Hesketh PJ, Herrstedt J.
Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference.
Ann Oncol 2006;17:20-28.
Schiffer CA et al.
Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology.
J Clin Oncol 2001;19:1519-1538.
Silliman C, Ambruso D, Boshkowv L.
Transfusion-related acute lung injury.
Blood 2005;105:2266-2273.
Smith TJ et al.
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
J Clin Oncol 2006;24:3187-3205.
Stone RM et al.
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
N Engl J Med 1995;332:1671-1677.
Uys A, Rapoport BL, Anderson R.
Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score.
Support Care Cancer 2004;12:555-560.
Wandt H et al.
New Strategies for Prophylactic Platelet Transfusion in Pateints with Hematologic Diseases.
The Oncologist 2001;6:446-450.
Wandt H et al.
Routine Prophylactic Transfusions Are Not Necessary in Patients with Acute Myeloid Leukemia - A Therapeutic Transfusion Strategy Is Safe and Cost Effective.
Blood 2005;106:abstract 428.
Zimmermann R, Eckstein R.
Indikation zur Erythrozytentransfusion.
Med Welt 2004;55:49-53.
© ONKODIN 2002-2011 | Kopieren nur für persönliche Verwendung genehmigt. |